Weill Cornell Newsroom > Press Releases
Dr. Zoltan Antal Named Chief of Pediatric Endocrinology at NewYork-Presbyterian and Weill Cornell Medicine
Distinguished pediatric endocrinologist takes on new role at the Phyllis and David Komansky Center for Children's Health
NEW YORK (October 18, 2016) – Dr. Zoltan Antal has been named chief of pediatric endocrinology at the Phyllis and David Komansky Center for Children's Health at NewYork-Presbyterian/Weill Cornell Medical Center and Weill Cornell Medicine, effective Aug. 1.
|Dr. Zoltan Antal|
In his new role, Dr. Antal oversees all clinical, research and educational activities in pediatric endocrinology. Dr. Antal is also the director of the Pediatric Diabetes Program in the Division of Pediatric Endocrinology, a pediatrician at NewYork-Presbyterian/Weill Cornell Medical Center and NewYork-Presbyterian/Phyllis and David Komansky Center for Children's Health, and associate professor of clinical pediatrics at Weill Cornell Medicine.
"The Department of Pediatrics is excited to announce Dr. Antal as chief of endocrinology," said Dr. Gerald Loughlin, pediatrician-in-chief at NewYork-Presbyterian/Weill Cornell and the Nancy C. Paduano Professor and chairman of the Department of Pediatrics at Weill Cornell Medicine. "His experience and knowledge as an academic physician will be a great asset to the future growth and development of our already outstanding pediatric endocrine program."
As chief of pediatric endocrinology, Dr. Antal will expand clinical services by offering new evening office hours at NewYork-Presbyterian/Weill Cornell as well as new daytime office hours at the Weill Cornell Medicine Primary Care practice at 2315 Broadway at West 84th Street. At NewYork-Presbyterian/Queens, he will improve outpatient office visits for children in need of general endocrine care as well as expand care for children with type 1 diabetes, including inpatient and outpatient consultations for newly diagnosed cases.
"Pediatric diabetes is increasingly prevalent in our country, and it is more important than ever to dedicate our best minds and resources to finding a cure and developing the highest quality treatment options for children in need," Dr. Antal said. "I am excited to expand my role here at NewYork-Presbyterian and Weill Cornell Medicine, and continue to provide the best care possible to all our patients."
Board certified in pediatrics and pediatric endocrinology, Dr. Antal is an expert in pediatric diabetes, growth and pubertal disorders, thyroid disorders, and the multiple hormone disorders that can result from childhood cancer treatments. His research focuses on pediatric diabetes care and includes ongoing prospective studies of psychosocial well-being in children with type 1 diabetes, and the incidence and effects of hyperglycemia on infection rates and outcomes in children with newly diagnosed acute leukemia. His work with long-term survivors of childhood cancer will expand his research on testicular function in adolescents and young adults following cancer therapy, facilitating development of more precise parameters to guide hormone replacement therapy for cancer survivors with testicular dysfunction. Dr. Antal's research has been published in numerous peer-reviewed journals, including the Journal of Pediatric Endocrinology and Metabolism, the Journal of Diabetes Science and Technology and the Journal of Clinical Research in Pediatric Endocrinology.
Dr. Antal serves on a number of committees, including NewYork-Presbyterian's Inpatient Hyperglycemia and Diabetes Task Force. In addition, he is a founding member of the Pediatric Glycemic Committee, a NewYork-Presbyterian/Weill Cornell and NewYork-Presbyterian/Columbia multidisciplinary committee dedicated to improving pediatric diabetes care by focusing on the individual needs of children with the disease. He also serves on the Komansky Center Improvement Quality Council, Resident Research Oversight Committee, Scholarship Oversight Committee, the Atkins-Cardio-Metabolic Curriculum Steering Committee and the Physician's Organization's Pediatric Care Delivery and Operations Subcommittee.
Dr. Antal received his B.S. in biology from Stony Brook University and earned his M.D. from St. George's University School of Medicine in Grenada, West Indies. He completed his residency in pediatrics in Brooklyn at SUNY Downstate Medical Center and Kings County Hospital, where he later served as chief resident.
Apart from his clinical work, Dr. Antal remains passionate about teaching, mentoring fellows, residents and medical students. He received Weill Cornell Medicine's Excellence in Teaching Award and directs the Division of Pediatric Endocrinology's annual Updates in Pediatric Endocrinology Continuing Medical Education course. He is involved in nursing education, and teaches at local and national education seminars on pediatric diabetes, precocious puberty and thyroid disorders in children.
NewYork-Presbyterian is one of the nation's most comprehensive healthcare delivery networks, focused on providing innovative and compassionate care to patients in the New York metropolitan area and throughout the globe. In collaboration with two renowned medical school partners, Weill Cornell Medicine and Columbia University College of Physicians & Surgeons, NewYork-Presbyterian is consistently recognized as a leader in medical education, groundbreaking research and clinical innovation.
NewYork-Presbyterian has four major divisions: NewYork-Presbyterian Hospital is ranked #1 in the New York metropolitan area by U.S. News and World Report and repeatedly named to the magazine's Honor Roll of best hospitals in the nation; NewYork-Presbyterian Regional Hospital Network is comprised of leading hospitals in and around New York and delivers high-quality care to patients throughout the region; NewYork-Presbyterian Physician Services connects medical experts with patients in their communities; and NewYork-Presbyterian Community and Population Health features the hospital's ambulatory care network sites and operations, community care initiatives and healthcare quality programs, including NewYork Quality Care, established by NewYork-Presbyterian, Weill Cornell and Columbia.
NewYork-Presbyterian is one of the largest healthcare providers in the U.S. Each year, nearly 29,000 NewYork-Presbyterian professionals deliver exceptional care to more than 2 million patients.
For more information, visit www.nyp.org and find us on Facebook, Twitter and YouTube.
Weill Cornell Medicine
Weill Cornell Medicine is committed to excellence in patient care, scientific discovery and the education of future physicians in New York City and around the world. The doctors and scientists of Weill Cornell Medicine—faculty from Weill Cornell Medical College, Weill Cornell Graduate School of Medical Sciences, and Weill Cornell Physician Organization—are engaged in world-class clinical care and cutting-edge research that connect patients to the latest treatment innovations and prevention strategies. Located in the heart of the Upper East Side's scientific corridor, Weill Cornell Medicine's powerful network of collaborators extends to its parent university Cornell University; to Qatar, where an international campus offers a U.S. medical degree; and to programs in Tanzania, Haiti, Brazil, Austria and Turkey. Weill Cornell Medicine faculty provide comprehensive patient care at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, NewYork-Presbyterian/Lower Manhattan Hospital and NewYork-Presbyterian/Queens. Weill Cornell Medicine is also affiliated with Houston Methodist. For more information, visit weill.cornell.edu.
Posted October 18, 2016 10:57 AM | Permalink to this post
September 14, 2016 - Johnson, Weill Cornell Medicine Launch Dual MBA/M.S.